tiprankstipranks
Madrigal (MDGL)
NASDAQ:MDGL
US Market
MDGL
Madrigal Pharmaceuticals
RESEARCH TOOLSreports
Want to see MDGL full AI Analyst Report?

Madrigal Pharmaceuticals (MDGL) Stock News & Sentiment

1,343 Followers
Madrigal Earnings Call: Rezdiffra Boom, Profits Delayed
Premium
Company Announcements
Madrigal Earnings Call: Rezdiffra Boom, Profits Delayed
13d ago
MDGL
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
MDGL
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
Premium
Company Announcements
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
19d ago
MDGL
Madrigal Pharmaceuticals Reclassifies Board Ahead of 2026 Meeting
Premium
Company Announcements
Madrigal Pharmaceuticals Reclassifies Board Ahead of 2026 Meeting
21d ago
8K
MDGL
Ritu Baral Reaffirms Buy on Madrigal Pharmaceuticals Following Updated Financial Model and Sustained Long-Term Upside Outlook
Premium
Ratings
Ritu Baral Reaffirms Buy on Madrigal Pharmaceuticals Following Updated Financial Model and Sustained Long-Term Upside Outlook
27d ago
MDGL
Madrigal’s Rezdiffra Drives Blockbuster‑Level First Year
Premium
Company Announcements
Madrigal’s Rezdiffra Drives Blockbuster‑Level First Year
3M ago
MDGL
Madrigal Pharmaceuticals: Rezdiffra’s Strong Launch, Expanding Prescriber Adoption, and Advancing Pipeline Underpin Buy Rating
Premium
Ratings
Madrigal Pharmaceuticals: Rezdiffra’s Strong Launch, Expanding Prescriber Adoption, and Advancing Pipeline Underpin Buy Rating
3M ago
MDGL
More MDGL News >

MDGL News on the Web

Baker Bros. Advisors LP Increases Stake in Incyte Corp with Strategic Acquisition
GuruFocus News
Neutral
Paulson takes new stake in Amicus, cuts position in Madrigal Pharma
TipRanks News
Bearish
Madrigal Pharmaceuticals price target raised to $709 from $640 at Truist
TipRanks News
Bullish
Madrigal Pharmaceuticals (MDGL) Receives a Buy from Barclays
TipRanks News
Neutral
Madrigal Pharmaceuticals price target lowered to $578 from $587 at Canaccord
TipRanks News
Bearish
Bank of America Securities Sticks to Their Hold Rating for Madrigal Pharmaceuticals (MDGL)
TipRanks News
Neutral
Madrigal Pharmaceuticals price target lowered to $649 from $652 at Evercore ISI
TipRanks News
Neutral
Truist Financial Sticks to Its Buy Rating for Madrigal Pharmaceuticals (MDGL)
TipRanks News
Neutral

News Score - Last 7 Days

Negative
MDGL
Sector Average
Media Buzz
This Week5 articles
Weekly Average4.75 articles
News Sentiment
This Week59%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDGL’s Media Buzz Sentiment?
5 articles about MDGL were published this week. In an average week, 4.75 articles are published.
    What is MDGL’s weekly average amount of articles?
    In an average week, 4.75 articles about MDGL are published.
      What is MDGL’s News Sentiment?
      59% of articles about MDGL were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        GOSSGossamer Bio
        CGENCompugen
        SPISpire Healthcare
        Showing the stocks with the most bullish news sentiment over the past week